<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Protein kinase C (PKC) consists of a family of closely related <z:chebi fb="0" ids="29108">Ca2+</z:chebi>/<z:chebi fb="0" ids="16247">phospholipid</z:chebi>-dependent phosphotransferase isozymes, most of which are present in the brain and are differentially activated by second messengers </plain></SENT>
<SENT sid="1" pm="."><plain>Calcium-dependent PKC activity may cause <z:mp ids='MP_0002229'>neuronal degeneration</z:mp> after ischemic insult </plain></SENT>
<SENT sid="2" pm="."><plain>PKC is also involved in trophic-factor signaling, indicating that activity of some PKC subspecies may be beneficial to the injured brain </plain></SENT>
<SENT sid="3" pm="."><plain>Therefore, we screened long-term changes in the expression of multiple PKC subspecies after focal <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> was produced by using an intraluminal suture for 30 min of 90 min </plain></SENT>
<SENT sid="5" pm="."><plain>In in situ hybridization experiments, <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels of PKC alpha, -beta, -gamma, -delta, -epsilon, and -zeta were decreased in the <z:mpath ids='MPATH_124'>infarct</z:mpath> core 4 hr after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and were lost completely 12 hr after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>In areas surrounding the core, PKC delta <z:chebi fb="2" ids="33699">mRNA</z:chebi> was specifically induced 4, 12, and 24 hr after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in the cortex </plain></SENT>
<SENT sid="7" pm="."><plain>At 3 and 7 d, the core and a rim around it showed increased <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels of PKC delta </plain></SENT>
<SENT sid="8" pm="."><plain>No other subspecies were induced </plain></SENT>
<SENT sid="9" pm="."><plain>At 2 d, immunoblotting demonstrated increased levels of PKC delta protein in the perifocal tissue, and immunocytochemistry revealed an increased number of PKC delta-positive neurons in the perifocal cortex </plain></SENT>
<SENT sid="10" pm="."><plain>In the core, PKC delta-positive macrophages and endothelial cells were seen </plain></SENT>
<SENT sid="11" pm="."><plain>Pretreatment with MK-801, an <z:chebi fb="0" ids="31882">NMDA</z:chebi> <z:chebi fb="68" ids="48706">antagonist</z:chebi>, inhibited cortical PKC delta <z:chebi fb="2" ids="33699">mRNA</z:chebi> induction </plain></SENT>
<SENT sid="12" pm="."><plain>The data show that focal <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> induces PKC delta <z:chebi fb="2" ids="33699">mRNA</z:chebi> and protein but not other PKC subspecies through the activation of <z:chebi fb="0" ids="31882">NMDA</z:chebi> receptors and that the upregulation lasts for several days in neurons of the perifocal zone </plain></SENT>
</text></document>